Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene

Carcinogenesis

Volumn 21, Issue 6, 2000, Pages 1259-1262

  Baross Francis, Agnes ^a   Milhausen, M Kate ^a   Andrew, Susan E ^b   Jevon, Gareth ^a   Jirik, Frank R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DNA REPAIR; FEMALE; GENE MUTATION; LYMPHOMA; MALE; MOUSE; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TRANSGENE;

EID: 0034082063     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.6.1259     Document Type: Article

References (22)

1. Loeb, L.A. (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51, 3075-3079.
2. Loeb, L.A. and Christians, F.C. (1996) Multiple mutations in human cancers. Mutat. Res., 350, 279-286.
3. Strauss, B.S. (1998) Hypermutability in carcinogenesis. Genetics, 148, 1619-1626.
4. Hoffmann, J.S. and Cazaux, C. (1998) DNA synthesis, mismatch repair and cancer. Int. J. Oncol. 12, 377-382.
5. Prolla, T.A. (1998) DNA mismatch repair and cancer. Curr. Opin. Cell Biol. 10, 311-316.
6. Toft, N.J. and Arends, M.J. (1998) DNA mismatch repair and colorectal cancer. J. Pathol., 185, 123-129.
7. Ricciardone, M.D., Ozcelik, T., Cevher, B., Ozdag, H., Tuncer, M., Gurgey, A., Uzunalimoglu, O., Cetinkaya, H., Tanyeli, A., Erken, E. and Ozturk, M. (1999) Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res., 59, 290-293.
8. Wang, Q., Lasset, C., Desseigne, F., Frappaz, D., Bergeron, C., Navarro, C., Ruano, E. and Puisieux, A. (1999) Neurofibromatosis and early onset of cancers in hMLHI-deficient children. Cancer Res., 59, 294-297.
9. Reitmair, A.H., Schmits, R., Ewel, A., Bapat, M., Redston, M., Mitri, A., Waterhouse, P., Mittrucker, H.-W., Wakeham, A., Liu, B., Thomason, A., Griesser, H., Gallinger, S., Ballhausen, W.G., Fishel, R. and Mak, T.W. (1995) MSH2 deficient mice are viable and susceptible to lymphoid tumors. Nature Genet., 11, 64-70.
10. de Wind, N., Dekker, M., Berns, A., Radman, M. and te Riele, H. (1995) Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination and predisposition to cancer. Cell, 82, 321-330.
11. Andrew, S.E., Reitmair, A.H., Fox, J., Hsiao, L., Francis, A., McKinnon, M., Mak, T.W. and Jink, F.R. (1997) Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice. Oncogene, 15, 123-129.
12. Baross-Francis, A., Andrew, S.E., Penney, J.E. and Jink, F.R. (1998) Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability. Proc. Natl Acad Sci. USA, 95, 8739-8743.
13. Prolla, T.A., Baker, S.M., Harris, A.C., Tsao, J.-L., Yao, X., Bronner, C.E., Zheng, B., Gordon, M., Reneker J., Arnheim, N., Shibata, D., Bradley, A. and Liskay, R.M. (1998) Tumor susceptibility and spontaneous mutation in mice deficient in M1h1, Pms1 and Pms2 DNA mismatch repair. Nature Genet., 18, 276-279.
14. Baker, S.M., Bronner, C.E., Zhang, L., Plug, A.W., Robatzek, M., Warren, G., Elliott, E.A., Yu, J., Ashley.T., Arnheim, N., Flavell, R.A. and Liskay, R.M. (1995) Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell. 82, 309-319.
15. Narayanan, L., Fritzell, J.A., Baker, S.M., Liskay, R.M. and Glazer, P.M. (1997) Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc. Natl Acad. Sci. USA, 94, 3122-3127.
16. Andrew, S.E., Xu, X.S., Baross-Francis, A., Narayanan, L., Milhausen, K., Liskay, R.M., Jirik, F.R. and Glazer, P.M. (2000) Mutagenesis in PMS2 and MSH2 deficient mice indicates differential repair of transversions and frameshitts. Carcinogenesis, in press.
17. Andrew, S.E., Pownall, S., Fox, J., Hsiao, L., Hambleton, J., Penney, J.E., Kohler, S.W. and Jink, F.R. (1996) A novel lacl transgenic mutation-detection system and its application to establish baseline mutation frequencies in the scid mouse. Mutat. Res., 357, 57-66.
18. Kohler, S.W., Provost, G.S., Kretz, P.L., Fieck, A., Sorge, J.A. and Short, J.M. (1990) The use of transgenic mice for short-term, in vivo mutagenecity testing. Genet. Anal. Tech. Appl. 77, 212-218.
19. Kohler, S.W., Provost, G.S., Fieck, A., Kretz, P.L., Bullock, W.O., Sorge, J.A., Putman, D.L. and Short, J.M. (1991) Spectra of spontaneous and mutagen-induced mutations in the lacl gene in transgenic mice. Proc. Natl Acad. Sci. USA, 88, 7958-7962.
20. Kolodner, R.D. and Marsischky, G.T. (1999) Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev., 9, 89-96.
21. Sands, A.T., Suraokar, M.B., Sanchez, A., Marth, J., Donehower, L.A. and Bradley, A. (1995) p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proc. Natl Acad. Sci. USA, 92, 8517-8521.
22. Buettner, V.L., Hill, K.A., Nishino, H., Schaid, D.J., Frisk, C.S. and Sommer, S.S. (1996) Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice. Oncogene, 13, 2407-2413.